Next Day Disclosure Return
Filed with HKEX · Stock code 6998 · · 6 pages · English
Edding Genor Group Holdings Limited on 6ix
Earlier from Edding Genor
- Voluntary announcement - first-in-human Phase I study data of GB268 presented at the esmo congress 2026
- Voluntary announcement - IND approval from the NMPA for Phase II clinical trial of GB268 in colorectal cancer
Later from Edding Genor
All Edding Genor news releasesFollow Edding Genor into a list and get an email when it puts out news.
Follow Edding Genor